Immix Biopharma, Inc. (IMMX)
12.74
+0.82
(+6.88%)
USD |
NASDAQ |
Sep 17, 16:00
12.72
-0.02
(-0.16%)
After-Hours: 19:51
Immix Biopharma Price : 12.74 for Sept. 17, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 16, 2026 | 12.28 | 12.46 | 11.75 | 11.92 | 1.422M |
| Sep 15, 2026 | 12.49 | 12.63 | 11.81 | 12.14 | 1.055M |
| Sep 14, 2026 | 12.44 | 12.59 | 11.98 | 12.21 | 1.080M |
| Sep 11, 2026 | 12.86 | 13.29 | 12.02 | 12.14 | 1.191M |
| Sep 10, 2026 | 12.08 | 12.77 | 11.91 | 12.70 | 1.656M |
| Sep 09, 2026 | 13.12 | 13.23 | 12.24 | 12.31 | 1.286M |
| Sep 08, 2026 | 13.70 | 13.89 | 12.75 | 13.25 | 1.420M |
| Sep 04, 2026 | 13.68 | 14.08 | 13.60 | 13.91 | 1.051M |
| Sep 03, 2026 | 14.14 | 14.14 | 13.52 | 13.83 | 987216.0 |
| Sep 02, 2026 | 14.00 | 14.23 | 13.42 | 13.96 | 1.578M |
| Sep 01, 2026 | 13.86 | 14.26 | 13.62 | 14.01 | 1.277M |
| Aug 31, 2026 | 13.70 | 14.15 | 13.52 | 14.03 | 1.327M |
| Aug 28, 2026 | 14.06 | 14.17 | 13.76 | 13.94 | 1.143M |
| Aug 27, 2026 | 14.03 | 14.61 | 13.77 | 14.31 | 1.511M |
| Aug 26, 2026 | 14.45 | 14.55 | 13.80 | 14.07 | 1.385M |
| Aug 25, 2026 | 13.60 | 15.10 | 13.48 | 14.47 | 3.661M |
| Aug 24, 2026 | 13.66 | 13.80 | 12.90 | 13.61 | 1.416M |
| Aug 21, 2026 | 13.36 | 13.76 | 13.12 | 13.66 | 1.511M |
| Aug 20, 2026 | 12.98 | 13.20 | 12.69 | 13.16 | 1.666M |
| Aug 19, 2026 | 11.99 | 13.19 | 11.99 | 13.19 | 1.975M |
| Aug 18, 2026 | 11.12 | 11.86 | 11.06 | 11.81 | 1.353M |
| Aug 17, 2026 | 10.88 | 11.53 | 10.74 | 11.34 | 1.249M |
| Aug 14, 2026 | 10.85 | 11.08 | 10.36 | 10.97 | 1.295M |
| Aug 13, 2026 | 11.51 | 11.55 | 10.82 | 10.92 | 1.142M |
| Aug 12, 2026 | 11.49 | 11.72 | 10.93 | 11.37 | 1.549M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Atossa Therapeutics, Inc. | 2.42 |
| ACADIA Pharmaceuticals, Inc. | 27.45 |
| Alnylam Pharmaceuticals, Inc. | 245.52 |
| Anika Therapeutics, Inc. | 20.99 |
| Savara, Inc. | 5.415 |
Price Related Metrics
| PEG Ratio | -1.292 |
| Price to Book Value | 3.981 |
| Earnings Yield | -6.91% |
| Market Cap | 911.36M |
| PEGY Ratio | -1.292 |